Mackayla L. Nelson

May 6, 2024 | mdpi.com | Jordan P. Hickey |Andrila E. Collins |Mackayla L. Nelson |helen CHEN

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Jul 24, 2023 | mdpi.com | Julia A. Pfeifer |Jordan P. Hickey |Andrila E. Collins |Mackayla L. Nelson

Abstract: Simple SummaryThis review focuses on rosiglitazone, a medication used to treat diabetes. Rosiglitazone lowers blood sugar levels by helping the body use insulin more efficiently. Individuals with diabetes have a higher risk of developing Alzheimer’s disease, a complex memory-loss disorder affecting millions of individuals globally. Although scientists do not know why, diabetes may interfere with the ability of the brain to respond to insulin.